A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 31/166 (2006.01) A61K 31/337 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2708168
Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating combination to a human melanoma patient during a treatment regimen, the combination including an alpha thymosin peptide and an antineoplastic heat shock apoptosis activator (HSAA) such as STA-4783 (and optionally an antineoplastic cytotoxic chemotherapeutic agent such as paclitaxel), and/or optionally one or more additional anti-melanoma agents.
L'invention concerne le traitement d'un mélanome ou d'une métastase de ce dernier chez un patient humain dans une polythérapie qui inclut l'administration d'une combinaison de traitement de mélanome à un patient humain atteint de mélanome pendant un régime de traitement, la combinaison incluant un peptide d'alpha thymosine et un activateur d'apoptose de choc thermique antinéoplasique (HSAA) tel que STA-4783 (et facultativement un agent chimiothérapeutique cytotoxique antinéoplasique tel que le paclitaxel), et/ou facultativement un ou plusieurs agents anti-mélanome supplémentaires.
Rios Israel
Tuthill Cynthia W.
Gowling Lafleur Henderson Llp
Sciclone Pharmaceuticals Inc.
LandOfFree
Treatment of melanoma with alpha thymosin peptides in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of melanoma with alpha thymosin peptides in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of melanoma with alpha thymosin peptides in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503668